OVID Health Systems offers state-of-the-art psychotherapies and conducts clinical studies in the field of psychedelic treatments.
‘Psychedelic’ translates into “manifesting the mind.” Our therapy team helps patients and clients to create the mindset for conscious explorations that enable you to transform parts of your self, engage in behavioral change, or develop new paths in life. Our concepts involve pharmacological and experiential methodologies.
OVID is supported by the MIND Foundation – our partnering science and education organization.
In OVID, we want to shape a new kind of mental health infrastructure by integrating psychedelic therapies.
Prof. Dr. med. Gerhard Gründer
Professor of Psychiatry at ZI Mannheim and Co-Founder of OVID
WHAT WE DO
Benefit from our ketamine-assisted psychotherapy in a professional framework built by medical doctors and psychotherapists. Make use of methods for inducing non-pharmacological altered states of consciousness like evocativbreathwork and stroboscopic light to work on psychological flexibility.learn More
Experience methods and technologies for altered states of consciousness to integrate insights and transform behavioral and emotional patterns.Learn More
Acquire the professonal foundations to safely and successfully apply innovative and evidence-based therapies with altered states of consciousness.Learn More
Research & clinical studies
Learn about our discoveries, pre-clinical research, and clinical trials.Learn More
WE ARE MORE THAN JUST A CLINIC
We are frontrunners for psychedelic therapies in Germany and Europe
We not only provide treatments but also conduct groundbreaking research in the field of psychedelics. OVID is participating in the first randomized clinical trial with psilocybin in Germany, one of the largest clinical trials worldwide at the Central Institute of Mental Health, Mannheim, and the Charité Universitätsmedizin.
We are well-connected with regulators, universities, and the medical community. Our partner organization MIND runs one of the largest high-quality conferences on psychedelic research and practice in Europe. MIND also helps to ensure that OVID remains a purpose-driven company that follows its goal to improve the lives of people and reaches groups that don’t have access to high-quality psychotherapies.
Our team includes renowned researchers, experienced medical doctors and psychotherapists, and key opinion leaders in the field. Our work has been covered by media outlets like DER SPIEGEL, die ZEIT, and ARD.Meet Our Team